BioSpace News Archive

Pharm Country

Natural Cycles Presents New, Real World Effectiveness Data at the 2019 American College of Obstetricians and Gynaecologists (ACOG) Annual Clinical and Scientific Meeting

New analysis further supports the effectiveness of Natural Cycles among users with different sleep patterns

May 2, 2019
·
4 min read
Business

Zymeworks Reports 2019 First Quarter Financial Results

Today reported financial results for the first quarter ended March 31, 2019.

May 2, 2019
·
11 min read
Thermo Fisher Scientific Announces Launch of Immune Cell Types Family of Assays

Applied Biosystems PureQuant Assays are a family of assays that accurately identify and quantify specific immune cell types in a mixed population of cells

May 2, 2019
·
1 min read
Drug Development

AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim to evaluate ATP128 in combination with BI754091

AMAL Therapeutics (AMAL), a Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, today announces that it has entered into a collaborative agreement with Boehringer Ingelheim

May 2, 2019
·
2 min read
Valens Announces Acceleration of Warrant Expiry Date

The proceeds from the exercise of the Warrants will be primarily used by the Company to continue to execute on its growth strategy, as well as general corporate and working capital purposes.

May 2, 2019
·
4 min read
Deals

Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock - May 2, 2019

Veracyte, Inc. announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $23.25 per share.

May 2, 2019
·
2 min read
Deals

Natera Announces First Quarter 2019 Earnings Conference Call

Natera, Inc. announced that it will release results for its first quarter ended March 31, 2019, after the market close on May 9, 2019.

May 2, 2019
·
1 min read
FDA

FDA Approves First Dengue Fever Vaccine - with Restrictions

Dengvaxia is approved for dengue disease caused by serotypes 1-4 in people 9 through 16 years of age who are living in areas of the U.S. who have had a laboratory-documented previous infection.

May 2, 2019
·
2 min read
·
Mark Terry
Drug Development

GSK Cuts Flu and Pneumonia Vaccines After Disappointing Data

In its announcement, GSK said the decision to cut the two programs were made following an analysis of available research results, including interim data from an ongoing Phase I study of the flu vaccine.

May 2, 2019
·
3 min read
·
Alex Keown
Policy

uBiome Places Co-CEOS on Administrative Leave, Taps Interim CEO as Billing Investigation Continues

Days after the Federal Bureau of Investigation raided the offices of Bay Area-based uBiome over allegations of illegal billing practices, the company’s board of directors placed Jessica Richman and Zac Apte, the co-founders and co-chief executive officers of the company, on administrative leave.

May 2, 2019
·
2 min read
·
Alex Keown